Delivra Health Brands has introduced LivRelief Itch Cream, a new product aimed at relieving itching caused by conditions like psoriasis, eczema, bug bites, and skin rashes. The cream uses a patented delivery system to penetrate the skin and combines itch relief with moisturizing properties to soothe irritated skin. With about 17% of Canadians experiencing itching issues, the product targets a significant market demand. The company emphasizes innovation and market research in developing solutions that meet consumer needs and plans to continue launching new health and wellness products.
Computeshare PTE. LTD., based in Singapore, announced the launch of its global membership ecosystem, with a closed beta set for July 16, 2026, in China. The platform integrates advanced AI services and a mature T3+T4 computing infrastructure to suppo...
During week 27 of 2026 (June 29 to July 3), Sampo Oyj bought back a total of 151,313 of its A-shares across multiple markets at an average price of €9.14 per share. This buyback is part of a larger program authorized by the company's annual general m...
Novartis has agreed to acquire Myricx Bio, a UK-based oncology company developing novel antibody-drug conjugates (ADCs), for up to $1.5 billion including $1.1 billion upfront. This acquisition combines Novartis's oncology expertise with Myricx Bio's ...
Novartis has agreed to acquire UK biotech Myricx Bio for up to $1.5 billion, including $1.1 billion cash upfront, to enhance its oncology portfolio with Myricx's novel antibody-drug conjugate (ADC) payloads. Myricx Bio specializes in a first-in-class...
The QAIAx AI City Hall Project has launched the world's first federally registered clinical trial for an AGI-governed smart city, emphasizing built-in privacy by anonymizing personal data. This project introduces a new AI technology and compliance pa...
